Article

The iDiabetes Platform: Enhanced Phenotyping of Patients with Diabetes for Precision Diagnosis, Prognosis and Treatment - study protocol for a cluster-randomised controlled study in Tayside, Scotland

2024-03-21

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Introduction and Aim</h4> Diabetes is a global health emergency with increasing prevalence and diabetes-associated morbidity and mortality. One of the challenges in optimising diabetes care is translating research advances in this heterogenous disease into clinical care. A potential solution is the introduction of precision medicine approaches into diabetes care. We aim to develop a digital p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c4d06f06-a895-5b5e-b987-07b188307405
DOI: 10.1101/2024.03.19.24304468

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The iDiabetes Platform: Enhanced Phenotyping of Patients with Diabetes for Precision Diagnosis, Prognosis and Treatment - study protocol for a cluster-randomised controlled study in Tayside, ScotlandDOI 10.1101/2024.03.19.24304468Read

iDiabetes platform-enhanced phenotyping of patients with diabetes for precision diagnosis, prognosis and treatment: study protocol for a cluster-randomised controlled study in Tayside, Scotland.Semantic proximity Read

AI Diabetes Clinic: AI-First Clinic Model for Type 2 Diabetes Diagnosis, Therapy Optimisation, and Complication Surveillance, with a Saudi Arabia Implementation BlueprintSemantic proximity Read

Clustering of adult-onset diabetes into novel subgroups guides therapy and improves prediction of outcomeSemantic proximity Read

A reproducible open-source framework for defining type 1 and type 2 diabetes research cohorts in routinely collected electronic health record dataSemantic proximity Read

Characterisation of type 2 diabetes subgroups and their association with ethnicity and clinical outcomes: a UK real-world data study using the East London DatabaseSemantic proximity Read

Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetesSemantic proximity Read

Identifying type 1 and 2 diabetes in population level data: assessing the accuracy of published approachesSemantic proximity Read

Derivation and validation of a type 2 diabetes treatment selection algorithm for SGLT2-inhibitor and DPP4-inhibitor therapies based on glucose-lowering efficacy: cohort study using trial and routine clinical dataSemantic proximity Read

Impact of COVID-19 on diagnoses, monitoring and mortality in people with type 2 diabetes: a UK-wide cohort study involving 14 million people in primary careSemantic proximity Read

Advancing Diabetes Care The Role of Personalized Medicine in Type 2 Diabetes ManagementSemantic proximity Read

Cohort profile: The Nanjing Diabetes Cohort database – a population-based surveillance cohortSemantic proximity Read

COVID-19 Disease in People with Diabetes in Scotland: Incidence, Severity and Risk Stratification Using Matched Case-Control and Prospective Cohort StudiesSemantic proximity Read